Existing arthritis drugs could help stop lingering lung problems that can last up to years after COVID-19 infections, according to a study from researchers at Charlottesville, Va.-based UVA Health ...

Scientists have developed a drug that can bring remarkable improvements to the lives of hundreds of thousands of arthritis sufferers. A single course of treatment will provide relief from ...

Tremfya is a prescription drug used for psoriasis and psoriatic arthritis. Find out about possible interactions with alcohol, ...

Arthritis drugs already available for prescription have the potential to halt lingering lung problems that can last months or years after COVID-19 infections, new research from the University of ...

A new oral treatment for psoriatic arthritis, Celgene's Otezla ... the immunology field currently dominated by the TNF blocker drugs, led by AbbVie's Humira. The oral treatment has a novel ...

Pfizer has received approval from the US FDA for its rheumatoid arthritis (RA) drug, Xeljanz, which is the first approved RA treatment in a new class of medicines known as Janus kinase inhibitors ...

This interview features Talisa King, who shared her experience navigating the health care system and living with rheumatoid ...

Arthritis drugs already available for prescription have the potential to halt lingering lung problems that can last months or years after COVID-19 infections, new research from the School of Medicine ...

and socioeconomic factors were linked to failure to respond to disease-modifying antirheumatic drugs in patients with psoriatic arthritis. Medscape Medical News, July 23, 2024 GRAPPA 2024 MSK ...

Sept 10 (Reuters) - UnitedHealth Group (UNH.N), opens new tab said on Tuesday it will remove AbbVie’s (ABBV.N), opens new tab blockbuster rheumatoid arthritis drug Humira from some of its lists ...

Plus: Here’s how Epic founder and CEO Judy Faulkner will keep her medical records company private, independent and ...